Cointime

Atom Bioscience & Pharmaceutical

company

About

Atom Bioscience is a clinical-stage biotechnology company.

  • 1 - 10

Highlights

Total Funding Amount
$48.07M
Funding Rounds
2
Investors
2

Details

Last Funding Type
Series C
Last Funding Money Raised
$45M
Industries
Biotechnology,Health Care
Founded date
Jan 1, 2012
Number Of Employee
1 - 10
Operating Status
Active

Atom Bioscience is a clinical-stage biotechnology company developing new treatments for inflammatory and metabolic diseases such as chronic gout and non-alcoholic steatohepatitis.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$48.07M
Atom Bioscience & Pharmaceutical has raised a total of $48.07M in funding over 2 rounds. Their latest funding was raised on Jan 5, 2022 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 5, 2022 Series C $45M 1 — — Detail
Jun 21, 2018 Series A $3.07M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
2
Atom Bioscience & Pharmaceutical is funded by 2 investors. Unifortune and Ch-gemstone capital are the most recent investors.
Investor Name Lead Investor Funding Round
Unifortune — Series C
Ch-gemstone capital — Series A
Cointime
เนื้อหา
บริษัท